Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-α

Blood

Volumn 95, Issue 8, 2000, Pages 2593-2599

  Zhou, Quansheng ^b   Zhao, Ji ^b   Al Zoghaibi, Fahad ^b   Zhou, Aimin ^b   Wiedmer, Therese ^b   Silverman, Robert H ^b   Sims, Peter J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; PHOSPHATIDYLSERINE; SCRAMBLASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0034656327     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2593     Document Type: Article

References (28)

1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227.
2. Doly J, Clvas A, Navarro S, Uze G. Type I interferons: expression and signalization. Cell Mol Life Sci. 1998;54:1109.
3. Darnell JEJ, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415.
4. Duhe RJ, Farrar WL. Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword. J Interferon Cytokine Res. 1998;18:1.
5. Der SD, Zhou AM, Williams BR, Silverman RH. Identification of genes differentially regulated by Interferon α, β, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A, 1998;95: 15,623.
6. 2+-dependent transbilayer movement of phospholipid. J Biol Chem. 1996;271: 17,205.
7. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase - a protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997; 272:18,240.
8. Zhao J Zhou Q, Wiedmer T, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem. 1998;273:6603.
9. 2+ binding site. Biochemistry. 1998; 37:14,860.
10. Verhoven B, Krahling S, Schlegel RA, Williamson P. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ. 1999;6:262.
11. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998;5:551.
12. Bevers EM, Comfurius P, Dekkers DWC, Harmsma M, Zwaal RFA. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance. Biol Chem. 1998;379:973.
13. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988;263:18,205.
14. McKendry R, John J, Flavell D, Muller M, Kerr IM, Stark GR. High-frequency mutagenesis of human calls and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc Natl Acad Sci U S A. 1991;88:11,455.
15. 2+-accelerated transbilayer movement of membrane phospholipids. Biochemistry. 1998;37:2356.
16. Kasukabe T, Okabe-Kado J, Honma Y. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines. Blood. 1997;89:2975.
17. Kasukabe T, Kobayashi H, Kaneko Y, Okabe-Kado J, Honma Y. Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b phospholipid scramblase gene. Biochem Biophys Res Commun. 1998;249:449.
18. Samanta H, Engel DA, Chao HM, Thakur A, Garcia-Blanco MA, Lengyel P. Interferons as gene activators. Cloning of the 5′ terminus and the control segment of an interferon activated gene. J Biol Chem. 1986;261:11,849.
19. Tanaka N, Ishihara M, Kitagawa M, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994;77:829.
20. Tamura T, Ishihara M, Lamphier MS, et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 1995;376:596.
21. Escalante CR, Yie J, Thanos D, Aggarwal AK. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 1998; 391:103.
22. Diaz C, Schroit AJ. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol. 1996;151:1.
23. Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol. 1994;31: 312.
24. Satta N, Toti F, Fressinaud E, Meyer D, Freyssinet J-M. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets. 1997;8:117.
25. Zhou QS, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood. 1998;92:1707.
26. 2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest. 1997;99: 2232.
27. Williams CD, Linch DC. Interferon alfa-2a. Br J Hosp Med. 1997;57:436.
28. Grander D, Einhorn S. Interferon and malignant disease - how does it work and why doesn't it always? Acta Oncol. 1998;37:331.